« Back
Home /
Octreotide (acetate)

Octreotide (acetate)

Item no.	HY-17365-50mg
Manufacturer	MedChem Express
CASRN	79517-01-4
Amount	50 mg
Quantity options	10 mM/1 mL 10 mg 25 mg 50 mg 5 mg
Category	Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
Purity	99.97
Citations	[1]Wang M, et al. Pharmacokinetic and pharmacodynamic study of a phospholipid-based phase separation gel for once a month administration of octreotide. J Control Release. 2016 May 28;230:45-56.\|[2]Kim S, et al. Treatment of Gastrin-Secreting Tumor With Sustained-Release Octreotide Acetate in a Dog. J Am Anim Hosp Assoc. 2015 Nov-Dec;51(6):407-12. Mol Med Rep. 2024 Jun;29(6):90.\|Nat Commun. 2023 Feb 21;14(1):962.\|Patent. US20240307504A1.\|Research Square Print. 2022 Aug.\|Basic Clin Pharmacol Toxicol. 2022 Jun 10.\|Biomacromolecules. 2024 Apr 23.\|Cell Mol Bioeng. 2022.\|Eur J Nucl Med Mol Imaging. 2024 Jul 18.\|Faculty of Biological and Environmental Sciences. University of Helsinki Finland. 2018 Dec.\|J Pharm Biomed Anal. 11 December 2021, 114518.\|J Pharm Biomed Anal. 2022: 115156.\|J Pharm Sci. 2022 Oct 10;S0022-3549(22)00454-3.\|Mol Cancer. 2024 Sep 20;23(1):205.
Smiles	O=C([C@@H](NC([C@H](CSSC[C@H](NC([C@](NC([C@@H](NC1=O)CCCCN)=O)([H])[C@H](O)C)=O)C(N[C@H](CO)[C@H](O)C)=O)NC([C@H](N)CC2=CC=CC=C2)=O)=O)CC3=CC=CC=C3)N[C@@H]1CC4=CNC5=CC=CC=C45.CC(O)=O
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	SMS 201-995 (acetate)
Shipping Condition	Cool pack
Available
Manufacturer - Type	Peptides
Manufacturer - Applications	COVID-19-immunoregulation
Manufacturer - Targets	Somatostatin Receptor
Shipping Temperature	Blue Ice
Storage Conditions	-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture and light)
Molecular Weight	1079.29
Product Description	Octreotide acetate, a long-acting synthetic analog of native somatostatin, inhibits growth hormone, glucagon, and insulin more potently.
Manufacturer - Research Area	Inflammation/Immunology; Cardiovascular Disease; Endocrinology; Cancer
Solubility	DMSO: 100 mg/mL (ultrasonic)\|H2O: 25 mg/mL (ultrasonic)
Manufacturer - Pathway	GPCR/G Protein; Neuronal Signaling
Clinical information	Launched

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-17365-50mg-safety-datasheet.pdf